Our first step was to examine the IHC expression of the two gluconeogenic enzymes (PCK1 and PCK2), and of the glucose transporter mediating glycolysis (GLUT1) in primary NSCLC samples, comparing expression profiles in LUAD versus LUSC. Here, PCK2 is linked to non-small cell lung carcinoma.